September 30, 2016 6:55 AM ET


Company Overview of Recro Pharma, Inc.

Executive Profile

Geraldine A. Henwood Ph.D.

Chief Executive Officer, President and Director, Recro Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Geraldine A. Henwood, also known as Gerri, Ph.D., has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She has been the Chief Executive Officer and President of RECRO Pharma, Inc. since November 15, 2007. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its ...

Corporate Headquarters

490 Lapp Road
Malvern, Pennsylvania 19355

United States

Phone: 484-395-2470
Fax: 484-395-2471

Board Members Memberships

Chief Executive Officer, President and Director
Chief Executive Officer and Director
Director and Member of Compensation Committee


Neumann University

Other Affiliations

Annual Compensation

Total Annual Compensation$734,281

Stocks Options

All Other Compensation$48,342
Exercisable Options$122,845
Unexercisable Options$434,755
Total Number of Options$557,600

Total Compensation

Total Annual Cash Compensation$782,623
Total Short Term Compensation$734,281
Other Long Term Compensation$48,342
Total Calculated Compensation$1,923,022

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Recro Pharma, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at